NitroMed Halts Sale of Drug

January 15, 2008, 7:37 am by Wall Street Journal

NitroMed is shutting down its effort to market and sell BiDil, a treatment for congestive heart failure and the first drug approved for use in a single racial group.

Read the full article

More from Wall Street Journal

Merck Insomnia Drug Has Positive Results
Wall Street Journal : February 6, 2012, 12:07 pm
Merck said it achieved positive results in Phase 3 trials of its experimental insomnia treatment, a key drug in the pharmaceutical giant's pipeline.

Stopping Sleepiness
Wall Street Journal : February 6, 2012, 9:17 am
The hunt is on for a so-called biomarker to gauge how sleepy a person really is—and what that means for his or her health.

Keeping Up With the Guys on a Snowmobile
Wall Street Journal : February 6, 2012, 9:11 am
Pastry chef Amanda Tutone stands out among the packs of snowmobilers in the Colorado Rockies. The petite 27-year-old is usually dressed head to toe in hot pink and is often the sole

Who Really Shouldn't Eat Gluten
Wall Street Journal : February 6, 2012, 8:40 am
A group of experts is proposing a new classification system for the gluten-related disorders plaguing a growing number of people world-wide.

Dogs Get Cancer, Hold Clues to Cures
Wall Street Journal : February 6, 2012, 8:39 am
Personalized medicine is expected someday to give a big boost to treating cancer. Researchers are hoping to speed up those therapeutic benefits by testing the concept in another group: pet dogs.